You are here: All Products  > 3SBio Has China Rights to Five Numab I-O Therapies following $15.2 Million Investment

3SBio Has China Rights to Five Numab I-O Therapies following $15.2 Million Investment

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.